PNC Financial Services Group
VNRX icon

PNC Financial Services Group’s VolitionRx Ltd VNRX Stock Holding History

PNC Financial Services Group’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15
Closed -$215 – 4827
2023
Q4 		$215 Buy
+15
New +$220 ﹤0.01% 4484

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

PNC Financial Services Group's VNRX Position: Q1 2024 in Review

PNC Financial Services Group sold out of VolitionRx Ltd (VNRX) in Q1 2024, closing a stake of 15 shares — an estimated $215 sold.

PNC Financial Services Group first reported a position in VNRX in Q4 2023 and held it in 1 quarter. The position peaked at $215 in Q4 2023. 24 funds tracked by Wall St. Rank hold VNRX as of Q1 2024.

  • PNC Financial Services Group reported no remaining VolitionRx Ltd position as of Q1 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 15 VolitionRx Ltd shares in Q1 2024, an estimated $215.
  • PNC Financial Services Group first reported a position in VolitionRx Ltd in Q4 2023 and held it in 1 quarter.
  • PNC Financial Services Group's VolitionRx Ltd position peaked at $215 in Q4 2023.
  • 24 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2024.

Based on PNC Financial Services Group's 13F filing for Q1 2024, filed 10 May 2024.